Krystal Brown

Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder

Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study

Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial

Preventive surgery after multiplex genetic panel testing (MGPT).

Impact of a genetic counseling requirement prior to genetic testing

Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance

Promoting breast cancer screening after multiplex genetic panel testing (MGPT) and genetic counseling.

A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi

Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

Phosphatidylglycerol Flip-Flop Suppression due to Headgroup Charge Repulsion

Lipid Flip-Flop in Binary Membranes Composed of Phosphatidylserine and Phosphatidylcholine

The effect of cholesterol on the intrinsic rate of lipid flip–flop as measured by sum-frequency vibrational spectroscopy